Human Endogenous Retroviruses in Neurological Diseases

Patrick Küry(Heinrich Heine University Düsseldorf), Avindra Nath(National Institutes of Health), Alain Créange(Assistance Publique – Hôpitaux de Paris), Antonina Dolei(University of Sassari), Patrice N. Marche(Inserm), Julian Gold(Queen Mary University of London), Gavin Giovannoni(Queen Mary University of London), Hans‐Peter Hartung(Heinrich Heine University Düsseldorf), Hervé Perron(Université Claude Bernard Lyon 1)
Trends in Molecular Medicine
March 18, 2018
Cited by 289Open Access
Full Text

Abstract

The causes of multiple sclerosis and amyotrophic lateral sclerosis have long remained elusive. A new category of pathogenic components, normally dormant within human genomes, has been identified: human endogenous retroviruses (HERVs). These represent ∼8% of the human genome, and environmental factors have reproducibly been shown to trigger their expression. The resulting production of envelope (Env) proteins from HERV-W and HERV-K appears to engage pathophysiological pathways leading to the pathognomonic features of MS and ALS, respectively. Pathogenic HERV elements may thus provide a missing link in understanding these complex diseases. Moreover, their neutralization may represent a promising strategy to establish novel and more powerful therapeutic approaches.


Related Papers

No related papers found

Powered by citation graph analysis